XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Condensed Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 30, 2019 $ 1,279,037 $ 106   $ 814,708 $ 474,309 $ (10,086)
Beginning balance (in shares) at Dec. 30, 2019   105,510        
Net income (loss) (1,174)       (1,174)  
Other comprehensive income (loss) (5,498)         (5,498)
Issuance of common stock for performance-based restricted stock units (in shares)   187        
Issuance of common stock for restricted stock units (in shares)   520        
Stock-based compensation 4,835     4,835    
Ending balance at Mar. 30, 2020 1,277,200 $ 106   819,543 473,135 (15,584)
Ending balance (in shares) at Mar. 30, 2020   106,217        
Beginning balance at Dec. 30, 2019 1,279,037 $ 106   814,708 474,309 (10,086)
Beginning balance (in shares) at Dec. 30, 2019   105,510        
Net income (loss) 138,575          
Other comprehensive income (loss) (30,461)          
Ending balance at Sep. 28, 2020 1,399,303 $ 107   826,859 612,884 (40,547)
Ending balance (in shares) at Sep. 28, 2020   106,742        
Beginning balance at Mar. 30, 2020 1,277,200 $ 106   819,543 473,135 (15,584)
Beginning balance (in shares) at Mar. 30, 2020   106,217        
Net income (loss) 181,200       181,200  
Other comprehensive income (loss) (27,092)         (27,092)
Issuance of common stock for restricted stock units   $ 1   (1)    
Issuance of common stock for restricted stock units (in shares)   484        
Stock-based compensation 2,647     2,647    
Ending balance at Jun. 29, 2020 1,433,955 $ 107   822,189 654,335 (42,676)
Ending balance (in shares) at Jun. 29, 2020   106,701        
Net income (loss) (41,451)       (41,451)  
Other comprehensive income (loss) 2,129         2,129
Exercise of stock options 191     191    
Exercise of stock options (in shares)   20        
Issuance of common stock for restricted stock units (in shares)   21        
Stock-based compensation 4,479     4,479    
Ending balance at Sep. 28, 2020 1,399,303 $ 107   826,859 612,884 (40,547)
Ending balance (in shares) at Sep. 28, 2020   106,742        
Beginning balance at Dec. 28, 2020 1,444,009 $ 107   830,971 651,844 (38,913)
Beginning balance (in shares) at Dec. 28, 2020   106,770        
Net income (loss) (3,192)       (3,192)  
Other comprehensive income (loss) 1,786         1,786
Issuance of common stock for performance-based restricted stock units (in shares)   135        
Issuance of common stock for restricted stock units (in shares)   203        
Fair value of warrants reclassified to warrant liabilities (4,345)     (4,345)    
Issuance of common stock from warrant exercises (in shares)   5        
Stock-based compensation 4,209     4,209    
Ending balance at Mar. 29, 2021 1,442,467 $ 107   830,835 648,652 (37,127)
Ending balance (in shares) at Mar. 29, 2021   107,113        
Beginning balance at Dec. 28, 2020 1,444,009 $ 107   830,971 651,844 (38,913)
Beginning balance (in shares) at Dec. 28, 2020   106,770        
Net income (loss) 46,027          
Other comprehensive income (loss) 6,210         6,210
Repurchases of common stock $ (35,116)          
Repurchases of common stock (in shares) (2,525)          
Ending balance at Sep. 27, 2021 $ 1,466,589 $ 108 $ (34,349) 835,662 697,871 (32,703)
Ending balance (in shares) at Sep. 27, 2021   108,165 (2,473)      
Beginning balance at Mar. 29, 2021 1,442,467 $ 107   830,835 648,652 (37,127)
Beginning balance (in shares) at Mar. 29, 2021   107,113        
Net income (loss) 28,261       28,261  
Other comprehensive income (loss) 2,438         2,438
Issuance of common stock for restricted stock units   $ 1   (1)    
Issuance of common stock for restricted stock units (in shares)   947        
Repurchases of common stock (6,145)   $ (6,145)      
Repurchases of common stock (in shares)     (411)      
Issuance of common stock from warrant exercises     $ 745 (745)    
Issuance of common stock from warrant exercises (in shares)   86 50      
Stock-based compensation 3,350     3,350    
Ending balance at Jun. 28, 2021 1,470,371 $ 108 $ (5,400) 833,439 676,913 (34,689)
Ending balance (in shares) at Jun. 28, 2021   108,145 (361)      
Net income (loss) 20,958       20,958  
Other comprehensive income (loss) 1,986         1,986
Issuance of common stock for restricted stock units (in shares)   20        
Repurchases of common stock $ (28,971)   $ (28,971)      
Repurchases of common stock (in shares) (2,114)   (2,114)      
Fair value of warrants reclassified to warrant liabilities $ (2,699)     (2,699)    
Issuance of common stock from warrant exercises     $ 22 (22)    
Issuance of common stock from warrant exercises (in shares)     2      
Stock-based compensation 4,944     4,944    
Ending balance at Sep. 27, 2021 $ 1,466,589 $ 108 $ (34,349) $ 835,662 $ 697,871 $ (32,703)
Ending balance (in shares) at Sep. 27, 2021   108,165 (2,473)